FDA Drug Application (084617) for DRALSERP by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number084617
Product Number001
FormTABLET;ORAL
Dosage25MG;0.1MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDRALSERP
Active IngredientHYDRALAZINE HYDROCHLORIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by SANDOZ